Welcome to our dedicated page for Medline news (Ticker: MDLN), a resource for investors and traders seeking the latest updates and insights on Medline stock.
Medline Inc. (Nasdaq: MDLN) is a healthcare company focused on medical-surgical ("med-surg") products and supply chain solutions that serve hospitals, surgery centers, physician offices and post-acute care facilities. The Medline news page on Stock Titan highlights company announcements that explain how it operates as what it describes as the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products.
News related to Medline often centers on capital markets activity and corporate milestones, such as the public filing of its registration statement on Form S-1 with the U.S. Securities and Exchange Commission, the pricing of its upsized initial public offering of Class A common stock, and the closing of that upsized offering on the Nasdaq Global Select Market under the symbol MDLN. These updates provide context on Medline’s transition to being a publicly traded company and its use of offering proceeds for debt repayment, general corporate purposes and transactions with pre-IPO owners.
Investors and observers can also find Medline announcements about participation in major healthcare and investor conferences, such as the J.P. Morgan Healthcare Conference. Such events can offer additional insight into how the company presents its med-surg product portfolio, supply chain capabilities and clinical solutions to the investment community.
This news page aggregates these types of press releases and corporate communications so readers can review Medline’s official statements over time. For anyone tracking MDLN, the page offers a focused view of the company’s own disclosures about its business focus, public listing, capital structure and engagement with the broader healthcare and financial markets.
Medline (Nasdaq: MDLN) reported second quarter 2026 net sales of $7.7 billion, up 11.6% year over year, with Organic Sales up 11.5%. Net income fell 58.3% to $139 million, mainly due to $336 million in losses from a fire at the Tracy, California distribution center before expected insurance recoveries, along with higher operating expenses and cost of goods sold.
Second quarter Adjusted EBITDA rose 13.4% to $1.06 billion, helped by a net $243 million IEEPA tariff refund benefit, including $332 million of refunds and $89 million of accrued customer repayments. For the first six months, net sales increased 11.1% to $15.0 billion, net income declined 42.3% to $378 million, and Adjusted EBITDA increased 1.9% to $1.84 billion. Net cash from operating activities was $1.1 billion and Free Cash Flow was $920 million. Medline raised its 2026 Organic Sales growth outlook to 9.0%–10.0% and lowered Adjusted EBITDA guidance to $3.3–$3.4 billion, excluding future IEEPA refund benefits.
Medline (Nasdaq: MDLN) plans to open an approximately 1 million-square-foot distribution center in Perris, California, expanding its state network and adding supply chain capacity and flexibility. The project follows a June 11 fire at Medline's Tracy facility and complements over 1.6 million square feet of new Northern California distribution space. With Perris and other recent additions, Medline expects its California distribution footprint to reach nearly 5 million square feet by mid-2027, with facilities incorporating technologies already used at other company sites. IDI Logistics will lead development of the Perris location.
Medline (Nasdaq: MDLN) signed a new Prime Vendor agreement with Allina Health, a Minneapolis-based healthcare system with 12 hospital campuses and more than 90 clinics across Minnesota and western Wisconsin.
The deal gives Allina Health access to Medline's medical-surgical portfolio and distribution capabilities to support supply reliability, consistency and supply chain resiliency across its hospitals and physician offices.
Medline (Nasdaq: MDLN) is leasing a 925,000-square-foot warehouse in Tracy, CA for near-term use and a 709,000-square-foot facility in Stockton, CA for January 2027. The more than 1.6 million square feet of new space replaces a 1 million-square-foot Tracy facility lost to fire on June 11 and expands Medline's customer-facing Northern California footprint by 45%. Statewide distribution center space is expected to approach 5 million square feet by mid-2027, including a new 1 million-square-foot site in Perris.
Medline (Nasdaq: MDLN) plans to report second quarter 2026 financial results on Wednesday, August 5, 2026, before the market opens.
The company will host a webcast and conference call at 9:30 a.m. ET / 8:30 a.m. CT, with access and replay via its investor relations website.
Medline (Nasdaq: MDLN) announced its first Prime Vendor agreement outside the U.S., signed by Medline Canada with Mohawk Medbuy, one of Canada's largest healthcare procurement groups. The deal covers warehouse and supply chain logistics for selected hospitals in Southwestern Ontario.
Beginning this fall, Medline Canada will implement a stockless distribution model, delivering customized low-unit quantities directly to care sites. Through its Supply Chain Solutions division, it will also provide delivery and storage optimization, automatic substitutions, backorder management with national brands, and data-driven tools to strengthen supply chain resiliency.
Medline (Nasdaq: MDLN) closed an upsized secondary offering of 72,554,594 Class A shares, sold by stockholders affiliated with Blackstone, Hellman & Friedman and Abu Dhabi Investment Authority at $37.00 per share.
The selling holders granted underwriters a 30-day option for up to 10,883,189 additional shares. Medline sold no shares and receives no proceeds.
Medline (Nasdaq: MDLN) announced upcoming investor conference participation by its executive leadership team.
CFO Mike Drazin and CPO Amanda Laabs will present at the William Blair 46th Annual Growth Stock Conference on June 3, 2026, while CEO Jim Boyle and CFO Mike Drazin will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. Live webcasts and 90-day replays will be available on Medline’s investor relations Events page.
Medline (Nasdaq: MDLN) priced an upsized secondary offering of 72,554,594 Class A shares by selling stockholders at $37.00 per share. Underwriters have a 30-day option for up to 10,883,189 additional shares. The offering should close on May 28, 2026, and Medline will not receive proceeds.
Medline (Nasdaq: MDLN) expanded its animal health portfolio with custom spay/neuter surgical packs for shelters, high‑volume clinics and veterinary practices. The ready-to-use packs group sterile instruments to streamline procedures, reduce prep time and support higher surgical throughput, aiming to ease staff burden and improve access to spay/neuter services.